These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4271567)

  • 1. Digestion of fibrin by thrombin.
    Triantaphyllopoulos DC; Chandra S
    Biochim Biophys Acta; 1973 Nov; 328(1):229-32. PubMed ID: 4271567
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.
    Pizzo SV; Schwartz ML; Hill RL; McKee PA
    J Clin Invest; 1972 Nov; 51(11):2841-50. PubMed ID: 4263497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human plasminogen by urokinase. Partial characterization of a pre-activation peptide.
    Walther PJ; Steinman HM; Hill RL; McKee PA
    J Biol Chem; 1974 Feb; 249(4):1173-81. PubMed ID: 4273519
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation of a low molecular weight form of plasminogen.
    Paoni NF; Castellino FJ
    Biochem Biophys Res Commun; 1975 Jul; 65(2):757-64. PubMed ID: 125089
    [No Abstract]   [Full Text] [Related]  

  • 6. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S
    Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fate of fibrinopeptides in the reaction between human plasmin and fibrinogen.
    Lahiri B; Shainoff JR
    Biochim Biophys Acta; 1973 Mar; 303(1):161-70. PubMed ID: 4267201
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Latallo ZS; Chang ML; Mattler LE
    Ser Haematol; 1973; 6(4):494-512. PubMed ID: 4277578
    [No Abstract]   [Full Text] [Related]  

  • 9. Zinc modulates thrombin adsorption to fibrin.
    Hopmeier P; Halbmayer M; Fischer M; Marx G
    Thromb Res; 1990 May; 58(3):293-301. PubMed ID: 2353341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin digestion by thrombin. Comparison with plasmin-digested fibrinogen.
    Kang EP; Triantaphyllopoulos DC
    Biochim Biophys Acta; 1977 Feb; 490(2):430-42. PubMed ID: 138448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The behavior of isotope labelled blood proteins in thrombosis.
    Strachan CJ; Scully MF; Kakkar VV
    Thromb Res; 1974 Feb; 4(2):303-18. PubMed ID: 4831006
    [No Abstract]   [Full Text] [Related]  

  • 12. The lysis of crosslinked human fibrin by plasmin yields initially a single molecular complex, D dimer-E.
    Gaffney PJ; Joe F
    Thromb Res; 1979; 15(5-6):673-87. PubMed ID: 158848
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for localization of polymerization sites in fibrinogen.
    Kudryk BJ; Collen D; Woods KR; Blombäck B
    J Biol Chem; 1974 May; 249(10):3322-5. PubMed ID: 4275342
    [No Abstract]   [Full Text] [Related]  

  • 14. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
    Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrinogen B (soluble fibrinogen), its nature and methods of determination].
    Belitser VA
    Lab Delo; 1980; (9):529-32. PubMed ID: 6157920
    [No Abstract]   [Full Text] [Related]  

  • 16. Human fibrinogen heterogeneities. I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates.
    Mosesson MW; Finlayson JS; Umfleet RA; Galanakis D
    J Biol Chem; 1972 Aug; 247(16):5210-9. PubMed ID: 4262568
    [No Abstract]   [Full Text] [Related]  

  • 17. Release of fibrinopeptides from fibrinolytic fibrinogen fragment E.
    Peyer A; Straub PW
    Thromb Diath Haemorrh; 1973 May; 29(2):300-12. PubMed ID: 4271587
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of plasmin in the degradation of the stroma-derived fibrin in human ovarian carcinoma.
    Wilhelm O; Hafter R; Henschen A; Schmitt M; Graeff H
    Blood; 1990 Apr; 75(8):1673-8. PubMed ID: 2139349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigations of fibrin clots formation under the effect of thrombin and ancystron].
    Savchuk OM; Chernyshov VI; Volkov HL
    Ukr Biokhim Zh (1999); 2004; 76(3):122-5. PubMed ID: 19621750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.